BACTERIOLOGY AND ANTIBACTERIAL SUSCEPTIBILITY OF TONSILLOPHARYNGITIS AND CHRONIC SUPPURATIVE OTITIS MEDIA CROSS SECTIONAL STUDY IN AL.HABOBI HOSPITAL-THI-QAR

Authors

  • mushtaq N.almalki Medical College/ThiQar University

Keywords:

tonsillopharyngitis, chronic suppurative otitis media, antibacterial susceptibility

Abstract

Antibacterial resistance is a great problem on proper management of   tonsillopharyngitis and chronic otitis media.To determine the antibacterial susceptibility of the common causative bacteria throat and ear swabs were sent for culture and antibiotic sensitivity testing from out patients attending AL.Habobi hospital over aperiod from September 2009 to September 2010. Of 102 patients with tonsillopharyngitis , Beta haemolytic streptococcus type A ,was the commonest cause accounting for 59.8% of all isolated bacteria, followed by 29.4% was staphylococcus.On other hand pseudomonas represent the top of the list of bacterial causes of chronic suppurative otitis media(46%) ,followed by staphylococcus aureus (27.6%). Amikacin has the greater chance of action among most isolated bacteria in this study.Sensitivity to commonly used antibacterial agent like amoxicillin, cephalosporin, pencillin, erythromycin and co-trimazole were less.

References

D.L.Cowan and John Hibbert, acute and chronic infection of pharynx and tonsil,Scott Brown(1997)vol. 5/4.

Gregg,Steele and Holzhuerter,1965;Mc-Kenzic and Brothwell1967;Rathban and Mallin,1977

Fairbanks,D.N.F.(1981) ,antimicrobial therapy for chronic otitis media,anuuls of otology,rhinology and laryngology 90,(suppl;94),58-62.

Hincheliffe,R(1961) prevalence of the commoner ear ,nose and throat condition in the adult rural population of Great British; British journal of preventative and social medicine,15,128-140.

R.P.Mills, management of chronic suppurative otitis media, Scott Brown (1997)vol.3/10/2.

Palva,T andHallstrom ,O.(1965)bacteriology of chronic otitis media,Archives of otolaryngology,82,354-364.

Picozzi,G.L.Browning,G.G. and Calder,I.T.(1983),control trials of gentamycin and hydrocortisone ear drop in the treatment of active chronic otitis media,clinical otolaryngology,8,367-368.

Harold ludman,complication of chronic suppurative otitis media,Scott Brown(1997)vol,3,12/1-27.

RogerF.Gray FRCS.,diseases of the mouth and pharynx,synopsis of otolaryngology 5th edition (1992) 334-335.

Chole Ra,SudhoffH H. chronic otitis media ,mastoiditis and petrositis.In; Cumming`s CW,Flint PW,Haughey BH, robbins KT,thoas JR,eds.otolaryngology:head&neck surgery. 4th ed. Philadeliphia,Pa:Mosby Elsevier;2005:chap 133.

Lindblad WJ(2008)."consideration for determining if anatural product is an effective wound healing agent"International journal of lower extremity eounds 7 (2): 75-81.

ForrestRD>(march1982),"Early history of wound treatment" JRSoc.med.75(3): 198-205.

M.Wainwright(1989)"Mould in ancient and more recent medicine" O.Mycologist 3(1):21-23.

Kingston W(june2008)"Irish contributions to the origins of antibiotics" Irish journal of medical science 177(2):87-92.

CaideronCB,Sabundayo BP(2007).Antimicrobial classifications:Drug for bugs.InSChwalbe R,steele- moore L.,Goodwin AC, Antimicrobial susceptibility testing protocols.CRC press,Taylor&France group.ISBN0-8247-4100-5

K.J.Lee,antimicrobial therapy in essential otolaryngology Head & neck surgery,7th ed(1999) 429-33.

Mosby`s Medical Dictionary,8th ed,2009,Elsevier.

Montorisi W,et al pefloxacin vesus ceftriaxone in single dose antibiotic prophylaxis in general clean contaminated surgery.The pefloxacin study group Minowa Chir 1997Dec;52(12):1539-48.

Hell K. use of long acting cephalosporin(ceftriaxone)for antimicrobial prophylaxis in abdominal andbiliary surgery .Eur Sur Res 1989;21(suppl) 1:6-13.

David N. F.Fairbanks, M.D.,antipseudomonal quinolone antibiotics,antimicrobial therapy in otolaryngology head and neck surgery 13th edition (2007)American Academy of otolaryngology-head&neck surgery Fourdation,Inc p15-16.

David N. F.Fairbanks, M.D.,antipseudomonal quinolone antibiotics,antimicrobial therapy in otolaryngology head and neck surgery 13th edition (2007)American Academy of otolaryngology-head&neck surgery Macrolides ketolide-azalide,p9-11

Ayaz Hussain Qureshi,et al, the prevalence of bacterial pathogen in throat infections and their susceptibility pattern,Pak Armed Forces Med J June 1997;47(1):34-6

Fam Tnact,1992;9:255-62.

Horn DL,ZabriskieJB.Austrian R,et al why have group A streptococcus remained susceptible to pencillin,Report on symposium clin infect Dis 1998;26:1341-5

A.H.C Loy,AL Tan PKSLu,microbiology of chronic suppurative otitis media in Singapore

Indutharon R, Haq J A, Aiyar S. Antibiotic in chronic suppurativ otitis media ; Abacteriological study.Ann O tol Rhinol Laryngol 1999;108(5):440-5.

Rotimi yo,okeowoPA,OlabiyiDA,BanjoTO,the bacteriology of chronic Suppurative otitis media.East Afr Med J 1992;69(7):394-7.

Fayed DF,Dahmash NS,alzeerAH,Shibl AM,Huraib SO,Abu-Aishah ,efficacy and safety of one –daily amikacin in combination with ceftazidine in critically ill adults with severe gram negative infection ,J chemother1996Dec;8(6):475-64

Karachlios GN,Houpas P ,TZiviskou E,PapalimneouV,Georgiou A,Karachaliou I,Halkiadki D. prospective randomized study of once – daily versus twice –daily amikacin regimens in patient s with systemic infection. IntJelin pharmacol ther1998 Oct;36(10):561-4

Maller R , Ahrene H, Holmen C,Lausen I ,Nilsson LE, Smedjegardj. Once- versus twice daily amikacin regmen : efficacy and safety in systemic gram- negative infections J Antimicrob chemother 1993 Jun;31(6);939-48.

Schmid L, Jeschko M,wilder-Smith C, Schfroth U,Thurliman B, pedrazzini A, Senntt, ceftriaxone and amikacin versus ceftazidne and amikacin in febrile granulocytopenia chemotherapy 1991;37(5):346-52.

Downloads

Published

2021-05-24

Issue

Section

Articles